Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04361617 · ClinicalTrials.gov registry record · NA

Nuts and Oil Pilot Study

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
34
Enrollment target

NCT04361617 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 34 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04361617, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target

Study Summary

Metabolic syndrome is considered to be a state of prediabetes and is a major risk factor for cardiovascular disease. Dietary interventions involving extra virgin olive oil (EVOO) supplementation and tree nut consumption can improve cardiometabolic health and reverse metabolic syndrome. The goal of this exploratory study is to establish the feasibility of using a novel measure - epigenetic age - to motivate behavior change and improve cardiometabolic health in individuals with metabolic syndrome.

Interventions

  • BEHAVIORAL Daily consumption of tree nuts and extra virgin olive oil

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2021-07-19
Est. Completion 2022-04-20
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT04361617

The ClinicalTrials.gov registry entry for NCT04361617 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Daily consumption of tree nuts and extra virgin olive oil is the first listed.

NCT04361617 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04361617 about?

NCT04361617 is a clinical study titled "Nuts and Oil Pilot Study". Metabolic syndrome is considered to be a state of prediabetes and is a major risk factor for cardiovascular disease. Dietary interventions involving extra virgin olive oil (EVOO) supplementation and tree nut consumption can improve cardiometabolic health and reverse metabolic syndrome. The goal of t...

What is the current status of trial NCT04361617?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2021-07-19. Estimated completion is 2022-04-20.

What interventions are being tested in trial NCT04361617?

The interventions under investigation include: Daily consumption of tree nuts and extra virgin olive oil (BEHAVIORAL).

Who is sponsoring clinical trial NCT04361617?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.